Bio-Rad Laboratories (BIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 331,551 | 463,388 | 574,231 | 912,973 | 649,938 |
Marketable Securities | 277,369 | 457,685 | 238,884 | 118,636 | 94,876 |
Receivables | 422,660 | 398,739 | 398,674 | 387,996 | 345,734 |
Inventories | 516,245 | 455,120 | 433,510 | 398,100 | 351,206 |
Income taxes - deferred | N/A | N/A | 53,777 | 48,021 | 43,102 |
Other current assets | 79,017 | 69,260 | 0 | 0 | 0 |
TOTAL | $1,757,479 | $1,936,682 | $1,798,155 | $1,975,346 | $1,562,674 |
Non-Current Assets | |||||
PPE Net | 414,401 | 416,938 | 349,501 | 333,617 | 302,417 |
Investments And Advances | 377,870 | 293,613 | 0 | 0 | 0 |
Intangibles | 783,958 | 756,357 | 728,430 | 567,862 | 532,405 |
Other Non-Current Assets | 55,082 | 39,913 | 220,717 | 185,939 | 138,357 |
TOTAL | $1,631,311 | $1,506,821 | $1,298,648 | $1,087,418 | $973,179 |
Total Assets | $3,388,790 | $3,443,503 | $3,096,803 | $3,062,764 | $2,535,853 |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 148,510 | 130,867 | 129,124 | 113,440 | 92,988 |
Accrued Expenses | 130,658 | 135,955 | 112,564 | 131,381 | 126,702 |
Other current liabilities | 116,573 | 113,043 | 114,787 | 93,104 | 106,136 |
TOTAL | $487,472 | $472,400 | $459,115 | $666,627 | $419,972 |
Non-Current Liabilities | |||||
Long Term Debt | 435,615 | 732,414 | 731,698 | 731,100 | 737,919 |
Deferred Revenues | 26,390 | 26,288 | 24,322 | 20,642 | N/A |
aiOther Non-Current Liabilities | 116,850 | 108,026 | 76,286 | 63,335 | 51,310 |
TOTAL | $714,596 | $955,563 | $893,306 | $855,618 | $836,668 |
Total Liabilities | $1,202,068 | $1,427,963 | $1,352,421 | $1,522,245 | $1,256,640 |
Shareholders' Equity | |||||
Shares Outstanding, K | 28,794 | 28,499 | 28,200 | 27,880 | 27,547 |
Common Shares | 3 | 3 | 3 | 3 | 3 |
Retained earnings | 1,606,117 | 1,528,327 | 1,359,910 | 1,181,687 | 996,197 |
Other shareholders' equity | 340,616 | 274,966 | 199,135 | 201,843 | 152,569 |
TOTAL | $2,186,722 | $2,015,540 | $1,744,382 | $1,540,519 | $1,279,213 |
Total Liabilities And Equity | $3,388,790 | $3,443,503 | $3,096,803 | $3,062,764 | $2,535,853 |